Lithium treatments: Single and multiple daily dosing

Canadian Journal of Psychiatry

Volumn 53, Issue 5, 2008, Pages 323-331

  Ljubicic, Dulijano ^a   Letica Crepulja, Marina ^a   Vitezic, Dinko ^a   Bistrovic, Ivana Ljubicic ^a   Ljubicic, Rudolf ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Lithium; Multiple daily dosing; Side effects; Single daily dosing

Indexed keywords

CALCIUM ION; CREATININE; LITHIUM CARBONATE; PHOSPHATE; PSYCHOTROPIC AGENT;

ANOREXIA; BLOOD BRAIN BARRIER; CALCIUM BLOOD LEVEL; CHEMOPROPHYLAXIS; CLINICAL TRIAL; COMA; COMPARATIVE STUDY; CONSCIOUSNESS DISORDER; CREATININE BLOOD LEVEL; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DROWSINESS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INTOXICATION; DRUG METABOLISM; DRUG SAFETY; DRUG TRANSPORT; DRUG URINE LEVEL; DYSARTHRIA; ELECTRONIC DATA INTERCHANGE; EVENING DOSAGE; FATIGUE; FEASIBILITY STUDY; GASTROINTESTINAL SYMPTOM; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERREFLEXIA; INDIGESTION; INFORMATION RETRIEVAL; KIDNEY CLEARANCE; KIDNEY FUNCTION; LETHARGY; LEUKOCYTE COUNT; MANIA; MOOD DISORDER; MUSCLE WEAKNESS; NAUSEA; NEUROTOXICITY; OLIGURIA; PATIENT COMPLIANCE; PHOSPHATE BLOOD LEVEL; POLYDIPSIA; POLYURIA; REVIEW; SEIZURE; SIDE EFFECT; STEADY STATE; THIRST; TREMOR; URINE VOLUME; VOMITING; WEIGHT GAIN;

EID: 45249089461     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805300507     Document Type: Review

References (37)

1. Linder MW, Keck PE Jr. Standards of laboratory practice: antidepressant drug monitoring. National Academy of Clinical Biochemistry. Clin Chem. 1998;44(5):1073-1084.
2. Ward ME, Musa MN, Bailey L. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994;34(4):280-285.
3. Perry PJ, Alexander B, Dunner FJ, et al. Pharmacokinetic protocol for predicting serum lithium levels. J Clin Psychopharmacol. 1982;2(2):114-118.
4. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217-222.
5. Muller-Oerlinghausen B. How should findings on antisuicidal effects of lithium be integrated into practical treatment decisions? Eur Arch Psychiatry Clin Neurosci. 2003;253(3):126-131.
6. Cipriani A, Pretty H, Hawton K, et al. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162(10):1805-1818.
7. Chen KP, Shen WW, Lu ML. Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry Clin Neurosci. 2004;58(1):25-29.
8. Ferrier IN, Ferrie LJ, Macritchie KA. Old drug, new data: revisiting . . . lithium therapy. Advan Psychiatr Treat. 2006;12(4):256-264.
9. Vestergaard P, Licht RW. 50 years with lithium treatment in affective disorders: present problems and priorities. World J Biol Psychiatry. 2001;2(1):18-26.
10. Dodds G. Lithium therapy. Scott Med J. 2000;45(6):171-173.
11. Lepkifker E, Sverdlik A, Iancu I, et al. Renal insufficiency in long-term lithium treatment. J Clin Psychiatry. 2004;65(6):850-856.
12. Shelley RK, Silverstone T. Single dose pharmacokinetics of 5 formulations of lithium: a controlled comparison in healthy subjects. Int Clin Psychopharmacol. 1986;1(4):324-331.
13. Fetner HH, Geller B. Lithium and tricyclic antidepressants. Psychiatr Clin North Am. 1992;15(1):223-224.
14. Kilts CD. The ups and downs of oral lithium dosing. J Clin Psychiatry. 1998;59(6):21-26.
15. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165-177.
16. Perry PJ, Dunner FJ, Hahn RL, et al. Lithium kinetics in single daily dosing. Acta Psychiat Scand. 1981;64(4):281-294.
17. Shammi C. Single versus multiple daily dosing of lithium: renal effects. J Clin Psychiatry. 2005;66(3):398-399.
18. Carson SW, Roberts SH. Lithium. In: Murphy JE, editor. Clinical Pharmacokinetics. 2nd ed. Bethesda (MD): American Society of Health-System Pharmacists; 2001; p 229-245.
19. Bowen RC, Grof P, Grof E. Less frequent lithium administration and lower urine volume. Am J Psychiatry. 1991;148(2):189-192.
20. Gitlin MJ. Lithium and the kidney: an updated review. Drug Saf. 1999;20(3):231-243.
21. Abraham G, Delva N, Waldron J, et al. Lithium treatment: a comparison of once-and twice-daily dosing. Acta Psychiatr Scand. 1992;85(1):65-69.
22. Kusalic M, Engelsmann F. Renal reactions to changes of lithium dosage. Neuropsychobiology. 1996;34(3):113-116.
23. Hunter R. Steady-state pharmacokinetics of lithium carbonate in healthy subjects. Br J Clin Pharmacol. 1988;25(3):375-380.
24. Schou M, Amdisen A, Thomsen K, et al. Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatments regimens. Psychopharmacology (Berl). 1982;77(4):387-390.
25. Hetmar O, Bolwig TG, Brun C, et al. Lithium: long-term effects on the kidney. Acta Psychiatr Scand. 1986;73(5):574-581.
26. Marples D, Christensen S, Christensen EI, et al. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest. 1995;95(4):1838-1845.
27. Hasler U, Mordasini D, Bens M, et al. Long term regulation of aquaporin-2 expression in vasopressin-responsive renal collecting duct principal cells. J Biol Chem. 2002;277(12):10379-10386.
28. Bichet DG. Lithium, cyclic AMP signaling, A-kinase anchoring proteins, and aquaporin-2. J Am Soc Nephrol. 2006;17(4):920-922.
29. Plenge P, Mellerup ET, Bolwig TG, et al. Lithium treatment: does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand. 1982;66(2):121-128.
30. Muir A, Davidson R, Silverstone T, et al. Two regimens of lithium prophylaxis and renal function. Acta Psychiatr Scand. 1989;80(6):579-583.
31. O'Donovan C, Hawkes J, Bowen R. Effect of lithium dosing schedule on urinary output. Acta Psychiatr Scand. 1993;87(2):92-95.
32. Amdisen A. Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet. 1977;2(2):73-92.
33. Kilts CD. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. J Clin Psychiatry. 2000;61(9):41-46.
34. Plenge P, Stensgaard A, Jensen HV, et al. 24-hour lithium concentration in human brain studied by Li-7 magnetic resonance spectroscopy. Biol Psychiatry. 1994;36(8):511-516.
35. Plenge P, Amin M, Agarwal AK, et al. Prophylactic efficacy of lithium administered every second day: a WHO multicentre study. Bipolar Disord. 1999;1(2):109-116.
36. Gadallah MF, Feinstein EI, Massry SG. Lithium intoxication: clinical course and therapeutic considerations. Miner Electrolyte Metab. 1988;14(2-3):146-149.
37. Gould TD, Manji HK. Glycogen Synthase Kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology. 2005;30(7):1223-1237.